AI-Powered Blood Test Enhances Early Detection of Ovarian Cancer
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read MorePosted by Andy Lundin | Sep 30, 2024 | Molecular Diagnostics, Unknown Origin & Other Cancer Types |
An AI-powered blood test combining DNA fragment analysis with protein biomarkers significantly improves early ovarian cancer detection.
Read MorePosted by Andy Lundin | Sep 23, 2024 | Cancer |
Dancer diagnoses in the U.S. remained below pre-pandemic levels in 2021, with fewer early-stage and late-stage diagnoses compared to 2020.
Read MorePosted by Andy Lundin | Sep 6, 2024 | Cancer |
Researchers developed a new nanomaterial-based technology that detects cancer mutant genes in blood with unparalleled sensitivity.
Read MorePosted by Andy Lundin | Sep 4, 2024 | Cancer, Histology |
A new AI model is capable of diagnosing multiple types of cancer, predicting patient survival, and identifying tumor molecular profiles.
Read MorePosted by Andy Lundin | Aug 28, 2024 | Cancer |
The FDA approved Illumina’s oncology comprehensive test as an IVD tool, along with its first two CDx indications for cancer patients.
Read More